1832 Asset Management
TECH icon

1832 Asset Management’s Bio-Techne TECH Stock Holding History

1832 Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-150,000
Closed -$7.72M – 712
2025
Q2 		$7.72M Buy
+150,000
New +$7.54M 0.01% 343
2023
Q4 		– Sell
-46,200
Closed -$3.14M – 902
2023
Q3 		$3.14M Buy
46,200
+27,500
+147% +$2.17M ﹤0.01% 421
2023
Q2 		$1.53M Buy
+18,700
New +$1.5M ﹤0.01% 530
2016
Q3 		– Sell
-1,116
Closed -$32K – 751
2016
Q2 		$32K Buy
+1,116
New +$28.7K ﹤0.01% 546

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

1832 Asset Management's TECH Position: Q3 2025 in Review

1832 Asset Management sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 150,000 shares — an estimated $7.72M sold.

1832 Asset Management first reported a position in TECH in Q2 2016 and held it in 4 quarters. The position peaked at $7.72M in Q2 2025. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • 1832 Asset Management reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • 1832 Asset Management sold 150,000 Bio-Techne shares in Q3 2025, an estimated $7.72M.
  • 1832 Asset Management first reported a position in Bio-Techne in Q2 2016 and held it in 4 quarters.
  • 1832 Asset Management's Bio-Techne position peaked at $7.72M in Q2 2025.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on 1832 Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.